Hoth Therapeutics Inc (HOTH)

10:14 AM

Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-001 - Contract Pharma

10:14 AM

Jul 29, 2025

What makes Hoth Therapeutics Inc. stock price move sharplyConsistent Income Focused Trade List Analyzed - metal.it

Jul 29, 2025

Jul 29, 2025

Hoth Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionInvestment Strategy Designed for Capital Protection - metal.it

Jul 29, 2025

Jul 29, 2025

Hoth Therapeutics to expand phase II trial of HT-001 to EU countries - Investing.com Australia

Jul 29, 2025

Jul 29, 2025

Cancer Treatment Breakthrough: Hoth Therapeutics Takes Phase II Trial Global with Major EU Expansion - Stock Titan

Jul 29, 2025

Jul 29, 2025

What is the dividend policy of Hoth Therapeutics Inc. stockDaily Trading Forecasts From AI Tools - jammulinksnews.com

Jul 29, 2025

Jul 28, 2025

What is the risk reward ratio of investing in Hoth Therapeutics Inc. stockInvest smarter with expert trading signals - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

When is Hoth Therapeutics Inc. stock expected to show significant growthDynamic portfolio growth - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

How strong is Hoth Therapeutics Inc. company’s balance sheetSuperior trading gains - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What catalysts could drive Hoth Therapeutics Inc. stock higher in 2025Maximize portfolio growth with strategic plans - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What institutional investors are buying Hoth Therapeutics Inc. stockFind market-beating stocks for your portfolio - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Why is Hoth Therapeutics Inc. stock attracting strong analyst attentionGrow your wealth steadily and securely - jammulinksnews.com

Jul 27, 2025

Jul 25, 2025

What analysts say about Hoth Therapeutics Inc. stockFree Wealth Management Insights - Autocar Professional

Jul 25, 2025

Jul 25, 2025

What drives Hoth Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional

Jul 25, 2025

Jul 24, 2025

Is Hoth Therapeutics Inc. a good long term investmentTriple returns potential - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

Hoth Therapeutics Inc. Stock Analysis and ForecastHigh-yield trading alerts - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Hoth Therapeutics shares fall 1.52% intraday after signing VA research deal to advance GDNF as breakthrough therapy for obesity and fatty liver. - AInvest

Jul 22, 2025

Jul 22, 2025

Hoth Therapeutics partners with VA to test GDNF therapy for obesity - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Hoth Therapeutics partners with VA to test GDNF therapy for obesity By Investing.com - Investing.com South Africa

Jul 22, 2025

Jul 22, 2025

New Weight Loss Drug Challenger GDNF Takes On Semaglutide in Landmark VA Obesity Study - Stock Titan

Jul 22, 2025

Jul 22, 2025

Why Hoth Therapeutics Inc. stock attracts strong analyst attentionElite Investor Club - Newser

Jul 22, 2025

Jul 15, 2025

How Hoth Therapeutics Inc. stock performs during market volatilitySwing Trade Signals - Newser

Jul 15, 2025

Jul 05, 2025

Hoth Therapeutics (NASDAQ:HOTH) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jul 05, 2025

Jun 30, 2025

Traumatic Brain Injury Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 30, 2025

Jun 25, 2025

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market | Daily Courier - FinancialContent

Jun 25, 2025

Jun 24, 2025

Hoth Therapeutics Advances HT-001 for Cancer Treatment - TipRanks

Jun 24, 2025

Jun 24, 2025

HT-001's Breakthrough in Oncology Supportive Care: A Game-Changer for Hoth Therapeutics? - AInvest

Jun 24, 2025

Jun 24, 2025

Hoth Therapeutics stock rises after positive Phase 2a trial results By Investing.com - Investing.com India

Jun 24, 2025